Harvest One Cannabis Inc. (TSXV: HVT) (OTCQX: HRVOF) ("Harvest One" or the "Company"), a uniquely positioned cannabis-infused CPG leader, announced today the launch of its new LivRelief^TM product SKU, Extra Strength Transdermal CBD Cream as part of its strategic growth and brand expansion initiatives for 2021.

Gord Davey, President & CEO of Harvest One, said "Harvest One's LivRelief^TM CBD Cream continues its momentum of being the top-selling SKU in the Infused Topicals category in Ontario for the twelve-month period ended March 2021, as ranked by dollars sold, based on OCS Sales Data. The Company is excited to announce the launch of its new LivRelief^TM Extra Strength Transdermal CBD Cream, which will launch on the Medical Cannabis by Shoppers™ platform in June 2021".

Pipeline development and product innovation are key strategic initiatives for Harvest One. The Company remains committed to research & development, and robust product development to ensure it continually meet the needs of the growing cannabis consumer base. Additionally, the Company intends to further develop its cannabis-infused topicals to bolster its leadership position in the market by expanding its offerings in Canada and such other jurisdictions in key global markets when and where legal.

The new LivRelief^TM Extra Strength Transdermal CBD Cream contains 750mgs of CBD and will offer consumers three times the amount of cannabinoids found in the LivRelief^TM CBD Cream. With Harvest One's Infused Topical portfolio of LivRelief^TM CBD Cream, LivRelief^TM 1:1 Cream formulation, and now LivRelief^TM Extra Strength Transdermal CBD Cream in the Company's portfolio, consumers are afforded more choice to better suit their individual needs.

For a more detailed description of each of our consumer brands, we encourage you to visit the portfolio pages our website; https://www.harvestone.com/portfolio/infused-topicals/ .

About Harvest One

Harvest One is a global cannabis infused CPG leader that develops and distributes premium health, wellness and selfcare products with a market focus on sleep and pain. Harvest One is a uniquely positioned company in the cannabis space with a focus on cannabis infused and non-infused consumer packaged goods. Harvest One owns and operates two subsidiaries; Dream Water Global and LivRelief. For more information, please visit www.harvestone.com.

Cautionary Note Regarding Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements include, among other things, statements with respect to when the new LivRelief^TM Extra Strength Transdermal CBD Cream will be available at Medical Cannabis by Shoppers Drug Mart, future expansion plans, initiatives and strategies of the Company, and the Company's performance, growth initiatives, profitability, production capacity and gain in market share.

These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: implications of the COVID-19 pandemic on the Company's operations; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the cannabis markets where the Company operates; changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; employee relations and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution, and sale of cannabis and cannabis-related products in the markets where the Company operates. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.

Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's AIF, and under the heading "Risks and Uncertainties" in the Company's Management's Discussion and Analysis dated October 28, 2020, for the year ended June 30, 2020, filed under the Company's profile on SEDAR at www.sedar.com.

Neither TSX-V nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) accept responsibility for the adequacy or accuracy of this release.

Investor Relations:
Jack Tasse
Investor Relations
This email address is being protected from spambots. You need JavaScript enabled to view it.
1-877-915-7934